P.011 Efficacy and safety of ravulizumab in adults with AQP4+ NMOSD: interim analysis from the ongoing phase 3 CHAMPION-NMOSD trial.Published in:2024By:Pittock, SJ;Barnett, M;Bennett, JL;Berthele, A;de Sèze, J;Levy, M;Nakashima, I;Oreja-Guevara, C;Palace, J;Paul, F;Pozzilli, C;Mashhoon, Y;Allen, K;Parks, B;Kim, H;Vorobeychik, GPublication type:Abstract